{"id":"https://openalex.org/W3023970307","doi":"https://doi.org/10.3389/fphar.2020.00527","title":"Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-Care","display_name":"Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-Care","publication_year":2020,"publication_date":"2020-05-07","ids":{"openalex":"https://openalex.org/W3023970307","doi":"https://doi.org/10.3389/fphar.2020.00527","mag":"3023970307","pmid":"https://pubmed.ncbi.nlm.nih.gov/32457602","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7221117"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2020.00527","doi":"https://doi.org/10.3389/fphar.2020.00527","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2020.00527","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2020.00527/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2020.00527/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032261500","display_name":"Cynthia Sung","orcid":"https://orcid.org/0000-0001-8603-4022","observed_orcids":["https://orcid.org/0000-0001-8603-4022"]},"institutions":[{"id":"https://openalex.org/I2799333108","display_name":"Health Sciences Authority","ror":"https://ror.org/02ybkn114","country_code":"SG","type":"government","lineage":["https://openalex.org/I1291357265","https://openalex.org/I2799333108"]},{"id":"https://openalex.org/I4210126319","display_name":"Duke-NUS Medical School","ror":"https://ror.org/02j1m6098","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596","https://openalex.org/I170897317","https://openalex.org/I4210126319"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Cynthia Sung","raw_affiliation_strings":["Health Services & Systems Research Programme, Duke-NUS Medical School, Singapore, Singapore","Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Services & Systems Research Programme, Duke-NUS Medical School, Singapore, Singapore","institution_ids":["https://openalex.org/I4210126319"]},{"raw_affiliation_string":"Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore","institution_ids":["https://openalex.org/I2799333108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031396654","display_name":"Liesbet Li-Bei Tan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799333108","display_name":"Health Sciences Authority","ror":"https://ror.org/02ybkn114","country_code":"SG","type":"government","lineage":["https://openalex.org/I1291357265","https://openalex.org/I2799333108"]}],"countries":["SG"],"is_corresponding":true,"raw_author_name":"Liesbet Tan","raw_affiliation_strings":["Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore","institution_ids":["https://openalex.org/I2799333108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085144330","display_name":"Lie Michael George Limenta","orcid":"https://orcid.org/0000-0002-1242-2783","observed_orcids":["https://orcid.org/0000-0002-1242-2783"]},"institutions":[{"id":"https://openalex.org/I2799333108","display_name":"Health Sciences Authority","ror":"https://ror.org/02ybkn114","country_code":"SG","type":"government","lineage":["https://openalex.org/I1291357265","https://openalex.org/I2799333108"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Michael Limenta","raw_affiliation_strings":["Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore","institution_ids":["https://openalex.org/I2799333108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013920649","display_name":"Ganga Ganesan","orcid":"https://orcid.org/0000-0002-9601-5404","observed_orcids":["https://orcid.org/0000-0002-9601-5404"]},"institutions":[{"id":"https://openalex.org/I1291357265","display_name":"Ministry of Health","ror":"https://ror.org/00mrhvv69","country_code":"SG","type":"government","lineage":["https://openalex.org/I1291357265"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Ganga Ganesan","raw_affiliation_strings":["Policy Research and Evaluation Division, Ministry of Health, Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Policy Research and Evaluation Division, Ministry of Health, Singapore, Singapore","institution_ids":["https://openalex.org/I1291357265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110131750","display_name":"Dorothy Toh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799333108","display_name":"Health Sciences Authority","ror":"https://ror.org/02ybkn114","country_code":"SG","type":"government","lineage":["https://openalex.org/I1291357265","https://openalex.org/I2799333108"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Dorothy Toh","raw_affiliation_strings":["Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore","institution_ids":["https://openalex.org/I2799333108"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004816118","display_name":"Cheng Leng Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799333108","display_name":"Health Sciences Authority","ror":"https://ror.org/02ybkn114","country_code":"SG","type":"government","lineage":["https://openalex.org/I1291357265","https://openalex.org/I2799333108"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Cheng Leng Chan","raw_affiliation_strings":["Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore","institution_ids":["https://openalex.org/I2799333108"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5031396654"],"corresponding_institution_ids":["https://openalex.org/I2799333108"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":2.4523,"has_fulltext":true,"cited_by_count":31,"citation_normalized_percentile":{"value":0.87861158,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"11","issue":null,"first_page":"527","last_page":"527"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":1.0},{"id":"https://openalex.org/keywords/stevens-johnson-syndrome","display_name":"Stevens-Johnson syndrome","score":0.8690000176429749},{"id":"https://openalex.org/keywords/toxic-epidermal-necrolysis","display_name":"toxic epidermal necrolysis","score":1.0},{"id":"https://openalex.org/keywords/severe-cutaneous-adverse-reactions","display_name":"severe cutaneous adverse reactions","score":0.890999972820282},{"id":"https://openalex.org/keywords/levetiracetam","display_name":"levetiracetam","score":0.8479999899864197},{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":0.996999979019165},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9139999747276306},{"id":"https://openalex.org/keywords/drug-safety-policy","display_name":"drug safety policy","score":0.6470000147819519},{"id":"https://openalex.org/keywords/precision-medicine","display_name":"precision medicine","score":0.675000011920929},{"id":"https://openalex.org/keywords/drug-utilization-patterns","display_name":"drug utilization patterns","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C31467283","wikidata":"https://www.wikidata.org/wiki/Q912147","display_name":"Genotyping","level":4,"score":0.7993907928466797},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.7962650656700134},{"id":"https://openalex.org/C2778337148","wikidata":"https://www.wikidata.org/wiki/Q410400","display_name":"Phenytoin","level":3,"score":0.6411492228507996},{"id":"https://openalex.org/C2777332695","wikidata":"https://www.wikidata.org/wiki/Q417227","display_name":"Levetiracetam","level":3,"score":0.5736863613128662},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5718980431556702},{"id":"https://openalex.org/C160798450","wikidata":"https://www.wikidata.org/wiki/Q4230870","display_name":"Concordance","level":2,"score":0.52311772108078},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.5127280950546265},{"id":"https://openalex.org/C521751864","wikidata":"https://www.wikidata.org/wiki/Q1729207","display_name":"Christian ministry","level":2,"score":0.48391538858413696},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4496304988861084},{"id":"https://openalex.org/C2780664588","wikidata":"https://www.wikidata.org/wiki/Q1878682","display_name":"Toxic epidermal necrolysis","level":2,"score":0.4453250467777252},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4344263970851898},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.35366207361221313},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.33118313550949097},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28988009691238403},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2629789710044861},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.232355535030365},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.2073255181312561},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.18719899654388428},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10944542288780212},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09980052709579468},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0776936411857605},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2020.00527","doi":"https://doi.org/10.3389/fphar.2020.00527","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2020.00527","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2020.00527/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7221117","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7221117","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:32457602","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32457602","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:d0262b1c3e8a47ffbac58255953e5df1","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d0262b1c3e8a47ffbac58255953e5df1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 11 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2020.00527","doi":"https://doi.org/10.3389/fphar.2020.00527","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2020.00527","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2020.00527/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3023970307.pdf","grobid_xml":"https://content.openalex.org/works/W3023970307.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1941773052","https://openalex.org/W1970924226","https://openalex.org/W1971946342","https://openalex.org/W2049902892","https://openalex.org/W2061631865","https://openalex.org/W2068042402","https://openalex.org/W2073057919","https://openalex.org/W2105178715","https://openalex.org/W2109108121","https://openalex.org/W2111819588","https://openalex.org/W2113610481","https://openalex.org/W2116243022","https://openalex.org/W2131940857","https://openalex.org/W2783815851","https://openalex.org/W2903060406","https://openalex.org/W2946928731"],"related_works":["https://openalex.org/W4385334784","https://openalex.org/W2109108121","https://openalex.org/W2116243022","https://openalex.org/W1536899529","https://openalex.org/W2009107589","https://openalex.org/W2068042402","https://openalex.org/W1821066651","https://openalex.org/W2127649617","https://openalex.org/W7161295322","https://openalex.org/W2084298979"],"abstract_inverted_index":{"In":[0,94],"April":[1],"2013,":[2],"the":[3,56,64,71,86,95,102,172,199,236,245],"Ministry":[4,34],"of":[5,11,26,31,35,58,73,89,105,148,165,201,213,218,238],"Health":[6,8,36],"and":[7,69,85,125,130,241],"Sciences":[9],"Authority":[10],"Singapore":[12,183],"jointly":[13],"issued":[14],"recommendations":[15,159],"for":[16,42,67,160,171,244],"HLA-B*15:02":[17,43,90,149,161],"genotyping":[18,44,162,220],"before":[19],"starting":[20],"carbamazepine":[21],"(CBZ)":[22],"in":[23,92,179,182,186,191],"new":[24,140],"patients":[25,47],"Asian":[27,193],"ancestry":[28],"as":[29,163],"standard":[30,164],"care.":[32],"The":[33,145],"also":[37,204],"approved":[38],"a":[39,177,210,219,224],"75%":[40],"subsidy":[41,49,170],"to":[45,155,176,222],"all":[46,111],"on":[48],"at":[50],"public":[51],"healthcare":[52],"institutions.":[53],"To":[54],"understand":[55],"impact":[57],"these":[59],"regulatory":[60],"decisions,":[61],"we":[62,99],"researched":[63],"usage":[65],"patterns":[66],"CBZ":[68,124,134,180],"levetiracetam,":[70],"trend":[72],"Stevens-Johnson":[74],"syndrome/":[75],"toxic":[76],"epidermal":[77],"necrolysis":[78],"(SJS/TEN)":[79],"reports":[80],"associated":[81,109,122],"with":[82,110,123,168,188,195],"antiepileptic":[83],"drugs":[84,113],"take-up":[87],"rates":[88],"tests":[91,150],"Singapore.":[93],"5-year":[96],"post-policy":[97],"period,":[98],"found":[100],"that":[101,189],"annual":[103,146],"number":[104,147,200],"reported":[106],"SJS/TEN":[107,120,181],"cases":[108,121,203],"anti-epileptic":[112],"was":[114],"significantly":[115],"decreased":[116,136],"by":[117,128,137,184],"57%":[118],"(p=0.015);":[119],"phenytoin":[126],"reduced":[127],"92%":[129],"42%":[131],"respectively.":[132],"New":[133],"users":[135,142],"31%":[138],"while":[139,234],"levetiracetam":[141],"approximately":[143,156],"doubled.":[144],"conducted":[151],"increased":[152],"from":[153],"444":[154],"1,200.":[157],"Regulatory":[158],"care":[166],"coupled":[167],"government":[169],"test":[173],"had":[174],"contributed":[175],"reduction":[178],">90%,":[185],"line":[187],"observed":[190],"other":[192],"countries":[194],"similar":[196],"policies.":[197],"Additionally,":[198],"phenytoin-SJS/TEN":[202],"declined.":[205],"Taken":[206],"together,":[207],"this":[208],"represents":[209],"successful":[211],"example":[212],"precision":[214],"medicine":[215,243],"through":[216],"implementation":[217],"program":[221],"reduce":[223],"rare":[225],"but":[226],"serious":[227],"adverse":[228],"drug":[229],"reaction":[230],"among":[231],"at-risk":[232],"individuals,":[233],"preserving":[235],"availability":[237],"an":[239],"effective":[240],"low-cost":[242],"broader":[246],"population.":[247]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":10}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-05-13T00:00:00"}